Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 76

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 76
---
 harm our business.

Our future development and
prospects depend to a large degree on the experience, performance and continued service of our senior management team, including members
of our Board of Directors. We have invested in our management team at all levels. We have entered into contractual arrangements with our
directors and senior management team with the aim of securing the services of each of them. However, retention of these services or the
identification of suitable replacements cannot be guaranteed. There can be no guarantee that the services of the current directors and
senior management team will be retained, or that suitably skilled and qualified individuals can be identified and employed, which may
adversely impact our ability to develop our technologies and/or provide our services at the time requested by our customers or our ability
to market our services and technologies, and otherwise to grow our business, could be impaired. The loss of the services of any of the
directors or other members of the senior management team and the costs of recruiting replacements may have a material adverse effect on
us and our commercial and financial performance.

The ability to continue to
attract and retain employees with the appropriate expertise and skills also cannot be guaranteed. Finding and hiring any additional personnel
and replacements could be costly and might require us to grant significant equity awards or other incentive compensation, which could
adversely impact our financial results, and there can be no assurance that we will have sufficient financial resources to do so. Effective
product development and innovation, upon which our success is dependent, is in turn dependent upon attracting and retaining talented technical
and scientific personnel, who represent a significant asset and serve as the source of our technological and product innovations. If we
are unable to hire, train and retain such personnel in a timely manner, the development and introduction of our products could be delayed
and our ability to sell our products and otherwise to grow our business will be impaired and the delay and inability may have a detrimental
effect upon our performance.

Risks related to global public health concerns

Public health crises, such as the COVID-19 pandemic, have had, and could in the future have, a negative effect on our business.

Pandemics
or disease outbreaks, such as the COVID-19 pandemic, have created and may continue to create significant volatility, uncertainty and economic
disruption in the markets we operate in and may negatively impact business and healthcare activity globally. In response to the COVID-19
pandemic, governments around the world imposed measures designed to reduce the transmission of